Medicina em FocoBook an appointment

EXAMS · SÃO PAULO

Anti-RNA polymerase antibodies: cost, procedure and uses

A blood test that helps your doctor assess scleroderma and plan follow-up care.

Self-pay starting atR$ 604.80 (≈ US$ 106, estimated) Estimated value in US dollars at the tourist exchange rate, updated daily; payment is made in Brazilian reais.
Prices updated on November 17, 2026. See the versions below.
Book an exam
Anti-RNA polymerase antibodies
Quick response. The test looks for antibodies in the blood against RNA polymerase, an enzyme. In people with systemic sclerosis (scleroderma), one study found more kidney involvement in those with these antibodies.

Understand the exam

RNA polymerase is an enzyme, and it has three classes: I, II and III. In systemic sclerosis, the body may produce antibodies against them.

Anti-RNA polymerase antibodies are among the antibodies linked to systemic sclerosis. In one study, people with these antibodies had more kidney involvement: 29%, compared with 11% in the remaining patients. The result therefore helps plan follow-up.

At the clinic, the available version is called Anti-RNA polymerase I antibodies. The 2013 classification criteria for systemic sclerosis (ACR/EULAR) use the antibody against RNA polymerase III, so check with your doctor whether version I is appropriate for your case.

How it is done

The test involves drawing blood from a vein in the arm with a thin needle. A small amount of blood goes into a tube and is sent for analysis.

The result goes to the doctor who ordered the test, who explains what it means together with your history, physical examination and other antibodies.

  • Testing for antibodies against RNA polymerase I in the medical evaluation of systemic sclerosis (scleroderma) or overlap syndrome with systemic sclerosis, conditions with an established clinical association with this antibody. Check your doctor's order to confirm that the requested subtype is I, since the 2013 classification criteria for systemic sclerosis (ACR/EULAR) use the antibody against RNA polymerase III.

Does the exam hurt?

Cost and health plans

ExamSelf-payDurationHealth plans
Anti-RNA polymerase I antibodiesFrom R$ 604.80 (≈ US$ 106, estimated)Confirm with the teamAsk the team about coverage

The team confirms the requested option, coverage, and conditions before booking.

Book an exam

Frequently asked questions

What does a positive anti-RNA polymerase result mean?

In people with systemic sclerosis, one study found more kidney involvement in those with anti-RNA polymerase antibodies. The doctor always makes the diagnosis, based on symptoms and other tests.

Does a negative result rule out scleroderma?

No, because no single test confirms or rules out systemic sclerosis. There are other antibodies associated with the disease, such as anticentromere antibodies and anti-Scl-70 (also called anti-topoisomerase I). These specific markers are usually mutually exclusive, meaning they rarely appear together in the same person.

What is the difference between anti-RNA polymerase and anti-Scl-70?

Anti-Scl-70 (anti-topoisomerase I) and anti-RNA polymerase antibodies target different enzymes, and each specific marker of systemic sclerosis is associated with a distinct pattern of skin involvement and other signs of the disease. In addition, while antibodies against RNA polymerase I or III are mainly associated with systemic sclerosis, anti-RNA polymerase II is not specific to this disease.

Is fasting required?

The team explains preparation and visit duration when you schedule.

How long do results take?

The team explains the turnaround time when assisting you.

Does my health plan cover the anti-RNA polymerase test?

Check the table on this page for plans with coverage on record. If your health plan is not listed, the team will confirm coverage for you.

What is the price of the test?

The self-pay price of the test is in the pricing table on this page.

Where we see patients

Rua Frei Caneca, 1380, térreo (Edifício Crystal Tower), Consolação, São Paulo-SP, CEP 01307-000, Brasil

Updated on